Solubility Advantage of Amorphous Ketoprofen. Thermodynamic and Kinetic Aspects by Molecular Dynamics and Free Energy Approaches. 2020

D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
Computational and Chemical Biology, Fondazione Istituto Italiano di Tecnologia, Genova 16163, Italy.

Thermodynamic and kinetic aspects of crystalline (c-KTP) and amorphous (a-KTP) ketoprofen dissolution in water have been investigated by molecular dynamics simulation focusing on free energy properties. Absolute free energies of all relevant species and phases have been determined by thermodynamic integration on a novel path, first connecting the harmonic to the anharmonic system Hamiltonian at low T and then extending the result to the temperature of interest. The free energy required to transfer one ketoprofen molecule from the crystal to the solution is in fair agreement with the experimental value. The absolute free energy of the amorphous form is 19.58 kJ/mol higher than for the crystal, greatly enhancing the ketoprofen concentration in water, although as a metastable species in supersaturated solution. The kinetics of the dissolution process has been analyzed by computing the free energy profile along a reaction coordinate bringing one ketoprofen molecule from the crystal or amorphous phase to the solvated state. This computation confirms that, compared to the crystal form, the dissolution rate is nearly 7 orders of magnitude faster for the amorphous form, providing one further advantage to the latter in terms of bioavailability. The problem of drug solubility, of great practical importance, is used here as a test bed for a refined method to compute absolute free energies, which could be of great interest in biophysics and drug discovery in particular.

UI MeSH Term Description Entries
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D007700 Kinetics The rate dynamics in chemical or physical systems.
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics

Related Publications

D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
January 2007, Molecular pharmaceutics,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
March 2010, Journal of pharmaceutical sciences,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
October 2013, Molecular pharmaceutics,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
January 2004, Molecular pharmaceutics,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
August 2015, Molecular pharmaceutics,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
October 2020, International journal of pharmaceutics,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
October 2011, Journal of pharmaceutical sciences,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
January 2014, Drug development and industrial pharmacy,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
October 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
D Gobbo, and P Ballone, and S Decherchi, and A Cavalli
February 1994, Physical review. B, Condensed matter,
Copied contents to your clipboard!